Tumor Biobank Preservation Project

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042425

Enrollment

Unknown

Registered

2021-01-21

Start date

2021-01-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fresh tissue or blood samples from patients who have been clinically diagnosed with cancer.

Exclusion criteria

Exclusion criteria: Tissue or blood sample that has been improperly sampled resulting in necrosis or contamination.

Design outcomes

Primary

Measure	Time frame
N/A;	—

Countries

China

Contacts

Public ContactHang Song

Nanjing Personal Oncology Biotechnology Co. Ltd

songhang@personaloncology.cn+86 15996343168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026